Epidemiology and outcomes research for MGUS, myeloma and amyloidosis
Sirohi, B., Powles, R.
(2006)
Epidemiology and outcomes research for MGUS, myeloma and amyloidosis.
EUROPEAN JOURNAL OF CANCER, 42 (11).
pp. 1671-1683.
ISSN 0959-8049
Full text not available from this repository.
Abstract
Epidemiology and outcomes research for MGUS, myeloma and amyloidosis The epidemiology of plasma cell dyscrasias clearly links to a complicated multi-factorial pathogenic pathway that at the individual patient level gives no clear indication of why the malignant process has occurred but factors in the environment and within the genome give clues and are discussed. MGUS is a pre-malignant disorder characterised by monoclonal plasma cell proliferation in the bone marrow and no end-organ damage; the patients are asymptomatic. Primary amyloidosis is a rare disorder that is characterised by deposition of amyloid fibrils composed of immunoglobulin light chain fragments; symptoms relate to the affected organ. Multiple myeloma is a malignant disease of plasma cells and with improvements in treatment, patients can now expect a doubling of median survival to 5 years, a 20% chance of surviving > 10 years and a 50% chance of complete remission (CR), morphological and biochemical. The challenge is now to determine exactly what this means to the individual myeloma patient in terms of benefit, and to society as a whole and this is the basis of 'outcomes research' which is discussed in this review. (c) 2006 Published by Elsevier Ltd.
Item Type: | Review Article |
---|---|
Authors (ICR Faculty only): | Powles, Raymond |
All Authors: | Sirohi, B., Powles, R. |
Uncontrolled Keywords: | monoclonal gammopathy; multiple myeloma; amyloidosis; epidemiology; outcomes research Primary systemic amyloidosis; stem-cell transplantation; quality-of-life; high-dose melphalan; immunoglobulin deposition disease; smoldering multiple-myeloma; bone-marrow-transplantation; brain natriuretic peptide; atomic-bomb survivors; non-hodgkins-lymphoma |
Research teams: | Clinical Units > Haemato-Oncology Unit |
Date Deposited: | 10 Aug 2007 21:06 |
Last Modified: | 01 Oct 2009 07:23 |
URI: | http://publications.icr.ac.uk/id/eprint/3880 |
Actions (login required)
![]() |
View Item |